Summary
Lam Research Corporation (LRCX) reported a significant increase in revenue and net income for the quarter ended September 26, 2010, compared to the same period in the prior year. Revenue more than doubled, driven by improved customer demand in the semiconductor industry following a downturn. The company's gross margin also improved, reflecting higher revenues, favorable product mix, and increased factory utilization. Operating expenses increased, primarily due to higher R&D and SG&A investments to support growth, but were partially offset by a reversal of restructuring charges. The balance sheet shows a healthy increase in cash and cash equivalents, indicating strong operational cash flow generation. The company also continued its share repurchase program, demonstrating a commitment to returning capital to shareholders. Overall, the filing suggests a positive recovery and growth trajectory for Lam Research.
Financial Highlights
49 data points| Revenue | $805.87M |
| Cost of Revenue | $428.55M |
| Gross Profit | $377.33M |
| R&D Expenses | $86.35M |
| SG&A Expenses | $72.14M |
| Operating Expenses | $153.33M |
| Operating Income | $223.99M |
| Interest Expense | $101K |
| Net Income | $193.72M |
| EPS (Basic) | $0.16 |
| EPS (Diluted) | $0.15 |
| Shares Outstanding (Basic) | 1.24B |
| Shares Outstanding (Diluted) | 1.25B |
Key Highlights
- 1Revenue surged to $805.9 million for the quarter ended September 26, 2010, a substantial increase from $318.5 million in the prior year period.
- 2Net income dramatically improved to $193.7 million, or $1.55 per diluted share, compared to $16.8 million, or $0.13 per diluted share, in the prior year period.
- 3Gross margin increased to 46.8% from 42.2% year-over-year, driven by higher volumes and a favorable product mix.
- 4Operating income saw a significant recovery, reaching $224.0 million, a substantial improvement from $29.3 million in the prior year quarter.
- 5Cash and cash equivalents, short-term investments, and restricted cash increased to $1.1 billion as of September 26, 2010, up from $992 million as of June 27, 2010.
- 6The company actively repurchased shares, utilizing $144.8 million for treasury stock purchases during the quarter, and announced an additional $250 million repurchase authorization.
- 7Research and Development (R&D) expenses as a percentage of revenue decreased to 10.7% from 22.4% year-over-year, indicating improved operating leverage despite increased R&D spending in absolute terms.